PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22544804-9	2012	Among patients with an alanine aminotransferase (ALT) level greater than the upper limit of normal at baseline, normalization of ALT occurred in 74% of patients receiving tenofovir DF and 31% of patients receiving placebo (P < 0.001).	Tenofovir	171-183	glutamic--pyruvic transaminase	Homo sapiens	23-47	
20600036-6	2010	RESULTS: In HBeAg-positive patients, tenofovir was most effective in inducing undetectable levels of HBV DNA (predicted probability, 88%), normalization of alanine aminotransferase (ALT) levels (66%), HBeAg seroconversion (20%), and hepatitis B surface antigen loss (5%); it ranked third in histologic improvement of the liver (53%).	Tenofovir	37-46	glutamic--pyruvic transaminase	Homo sapiens	156-180	
33524314-0	2021	Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial.	Tenofovir	11-40	glutamic--pyruvic transaminase	Homo sapiens	125-149	
33880839-0	2021	Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.	Tenofovir	64-93	glutamic--pyruvic transaminase	Homo sapiens	11-35	
33880839-0	2021	Changes in alanine aminotransferase levels after switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in HIV-positive people without viral hepatitis in the Swiss HIV Cohort Study.	Tenofovir	95-98	glutamic--pyruvic transaminase	Homo sapiens	11-35	
25075941-0	2014	The Use of tenofovir disoproxil fumarate in hepatitis B e antigen-positive patients with normal levels of alanine aminotransferase.	Tenofovir	11-40	glutamic--pyruvic transaminase	Homo sapiens	106-130	
21086562-5	2010	In one patient with an alanine aminotransferase (ALT) flare, tenofovir was added after 3 mo of treatment.	Tenofovir	61-70	glutamic--pyruvic transaminase	Homo sapiens	23-47